325 related articles for article (PubMed ID: 16323006)
1. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.
Charlotte F; Doghmi K; Cassoux N; Ye H; Du MQ; Kujas M; Lesot A; Mansour G; Lehoang P; Vignot N; Capron F; Leblond V
Virchows Arch; 2006 Apr; 448(4):506-16. PubMed ID: 16323006
[TBL] [Abstract][Full Text] [Related]
2. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
3. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
4. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
[TBL] [Abstract][Full Text] [Related]
5. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
[TBL] [Abstract][Full Text] [Related]
6. BCL10 expression and localization in ocular adnexa MALT lymphomas: a comparative cytogenetic and immunohistochemical study.
Cerrone M; Collina F; De Chiara A; Corazzelli G; Curcio MP; De Renzo A; Russo F; Cantile M; Staibano S; Strianese D; Tranfa F; Botti G; De Rosa G; Franco R
Histol Histopathol; 2014 Jan; 29(1):77-87. PubMed ID: 23846624
[TBL] [Abstract][Full Text] [Related]
7. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
8. BCL10 expression in ocular adnexal lymphomas.
Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
10. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.
Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM
Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of ocular adnexal MALT lymphoma].
Xu WW; Zhang MN; Wei RL
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):299-303. PubMed ID: 20654054
[TBL] [Abstract][Full Text] [Related]
12. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.
Bailey EM; Ferry JA; Harris NL; Mihm MC; Jacobson JO; Duncan LM
Am J Surg Pathol; 1996 Aug; 20(8):1011-23. PubMed ID: 8712288
[TBL] [Abstract][Full Text] [Related]
13. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
14. The clinical characteristics and treatment results of ocular adnexal lymphoma.
Woo JM; Tang CK; Rho MS; Lee JH; Kwon HC; Ahn HB
Korean J Ophthalmol; 2006 Mar; 20(1):7-12. PubMed ID: 16768184
[TBL] [Abstract][Full Text] [Related]
15. No evidence of a correlation between BCL10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma.
Adachi A; Tamaru J; Kaneko K; Kuroda H; Miura I; Kojima T; Hoshino S; Ichinohasama R; Itoyama S
Pathol Int; 2004 Jan; 54(1):16-25. PubMed ID: 14674990
[TBL] [Abstract][Full Text] [Related]
16. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract][Full Text] [Related]
17. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit.
Izambart C; Robert PY; Petellat F; Petit B; Gastaud P; Lagier J; Labrousse F; Adenis JP
Orbit; 2008; 27(5):345-9. PubMed ID: 18836931
[TBL] [Abstract][Full Text] [Related]
18. Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions.
Yoon JS; Ma KT; Kim SJ; Kook K; Lee SY
Ophthalmic Plast Reconstr Surg; 2007; 23(2):94-9. PubMed ID: 17413620
[TBL] [Abstract][Full Text] [Related]
19. Marginal zone lymphoma of the lacrimal gland spreading to the lung and the bone marrow 11 years after first symptoms.
Zimpfer A; Freund MC; Dirnhofer S; Gunsilius E; Streubel B; Chott A; Tzankov A
Virchows Arch; 2006 Mar; 448(3):361-5. PubMed ID: 16328352
[TBL] [Abstract][Full Text] [Related]
20. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
